2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline

C114H102ClN19O2 — CID 161071205

IUPAC2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline
SMILESCOc1cc2c(cc1OC)N=C(CCc1cnc3ccccc3n1)C2.Cc1cc2c(cc1C)N=C(CCc1cnc3ccccc3n1)C2.Cc1cc2c(cc1Cl)N=C(CCc1cnc3ccccc3n1)C2.Cn1c(CCc2ccc3ccccc3n2)nc2ccccc21.Cn1c(CCc2cnc3ccccc3n2)nc2ccccc21.c1ccc2c(c1)CC(CCc1cnc3ccccc3n1)=N2
InChIInChI=1S/C20H19N3O2.C20H19N3.C19H16ClN3.C19H17N3.C18H16N4.C18H15N3/c1-24-19-10-13-9-14(22-18(13)11-20(19)25-2)7-8-15-12-21-16-5-3-4-6-17(16)23-15;1-13-9-15-11-16(22-20(15)10-14(13)2)7-8-17-12-21-18-5-3-4-6-19(18)23-17;1-12-8-13-9-14(22-19(13)10-16(12)20)6-7-15-11-21-17-4-2-3-5-18(17)23-15;1-22-18-9-5-4-8-17(18)21-19(22)13-12-15-11-10-14-6-2-3-7-16(14)20-15;1-22-17-9-5-4-8-16(17)21-18(22)11-10-13-12-19-14-6-2-3-7-15(14)20-13;1-2-6-16-13(5-1)11-14(20-16)9-10-15-12-19-17-7-3-4-8-18(17)21-15/h3-6,10-12H,7-9H2,1-2H3;3-6,9-10,12H,7-8,11H2,1-2H3;2-5,8,10-11H,6-7,9H2,1H3;2-11H,12-13H2,1H3;2-9,12H,10-11H2,1H3;1-8,12H,9-11H2
InChIKeyUERHIIZIZBTZQZ-UHFFFAOYSA-N
MW1805.65 g/mol
LogP24.37
Rot. Bonds20

About 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline

2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline (PubChem CID 161071205) has the molecular formula C114H102ClN19O2 and a molecular weight of 1805.65 g/mol. Its IUPAC name is 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline.

Molecular Properties

Compound Name2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline
PubChem CID161071205
Molecular FormulaC114H102ClN19O2
Molecular Weight1805.65 g/mol
Exact Mass1803.82
IUPAC Name2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline
SMILESCOc1cc2c(cc1OC)N=C(CCc1cnc3ccccc3n1)C2.Cc1cc2c(cc1C)N=C(CCc1cnc3ccccc3n1)C2.Cc1cc2c(cc1Cl)N=C(CCc1cnc3ccccc3n1)C2.Cn1c(CCc2ccc3ccccc3n2)nc2ccccc21.Cn1c(CCc2cnc3ccccc3n2)nc2ccccc21.c1ccc2c(c1)CC(CCc1cnc3ccccc3n1)=N2
InChIInChI=1S/C20H19N3O2.C20H19N3.C19H16ClN3.C19H17N3.C18H16N4.C18H15N3/c1-24-19-10-13-9-14(22-18(13)11-20(19)25-2)7-8-15-12-21-16-5-3-4-6-17(16)23-15;1-13-9-15-11-16(22-20(15)10-14(13)2)7-8-17-12-21-18-5-3-4-6-19(18)23-17;1-12-8-13-9-14(22-19(13)10-16(12)20)6-7-15-11-21-17-4-2-3-5-18(17)23-15;1-22-18-9-5-4-8-17(18)21-19(22)13-12-15-11-10-14-6-2-3-7-16(14)20-15;1-22-17-9-5-4-8-16(17)21-18(22)11-10-13-12-19-14-6-2-3-7-15(14)20-13;1-2-6-16-13(5-1)11-14(20-16)9-10-15-12-19-17-7-3-4-8-18(17)21-15/h3-6,10-12H,7-9H2,1-2H3;3-6,9-10,12H,7-8,11H2,1-2H3;2-5,8,10-11H,6-7,9H2,1H3;2-11H,12-13H2,1H3;2-9,12H,10-11H2,1H3;1-8,12H,9-11H2
InChIKeyUERHIIZIZBTZQZ-UHFFFAOYSA-N
XLogP24.37
TPSA245.33 Ų
H-Bond Donors
H-Bond Acceptors21
Rotatable Bonds20
Heavy Atoms136
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001805.65
LogP ≤ 524.37
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1021

Analyze 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline?
The IUPAC name of 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline (CID 161071205) is 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline.
What is the SMILES notation for 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline?
The canonical SMILES for 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline is COc1cc2c(cc1OC)N=C(CCc1cnc3ccccc3n1)C2.Cc1cc2c(cc1C)N=C(CCc1cnc3ccccc3n1)C2.Cc1cc2c(cc1Cl)N=C(CCc1cnc3ccccc3n1)C2.Cn1c(CCc2ccc3ccccc3n2)nc2ccccc21.Cn1c(CCc2cnc3ccccc3n2)nc2ccccc21.c1ccc2c(c1)CC(CCc1cnc3ccccc3n1)=N2.
What is the InChIKey of 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline?
The InChIKey is UERHIIZIZBTZQZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H19N3O2.C20H19N3.C19H16ClN3.C19H17N3.C18H16N4.C18H15N3/c1-24-19-10-13-9-14(22-18(13)11-20(19)25-2)7-8-15-12-21-16-5-3-4-6-17(16)23-15;1-13-9-15-11-16(22-20(15)10-14(13)2)7-8-17-12-21-18-5-3-4-6-19(18)23-17;1-12-8-13-9-14(22-19(13)10-16(12)20)6-7-15-11-21-17-4-2-3-5-18(17)23-15;1-22-18-9-5-4-8-17(18)21-19(22)13-12-15-11-10-14-6-2-3-7-16(14)20-15;1-22-17-9-5-4-8-16(17)21-18(22)11-10-13-12-19-14-6-2-3-7-15(14)20-13;1-2-6-16-13(5-1)11-14(20-16)9-10-15-12-19-17-7-3-4-8-18(17)21-15/h3-6,10-12H,7-9H2,1-2H3;3-6,9-10,12H,7-8,11H2,1-2H3;2-5,8,10-11H,6-7,9H2,1H3;2-11H,12-13H2,1H3;2-9,12H,10-11H2,1H3;1-8,12H,9-11H2.
What are the key properties of 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline?
2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline has a molecular weight of 1805.65 g/mol, XLogP of 24.37, 20 rotatable bonds, 0 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(6-chloro-5-methyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethoxy-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(5,6-dimethyl-3H-indol-2-yl)ethyl]quinoxaline;2-[2-(3H-indol-2-yl)ethyl]quinoxaline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoline;2-[2-(1-methylbenzimidazol-2-yl)ethyl]quinoxaline is sourced from PubChem (CID 161071205), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).